Photo-activatable compound, its preparation and therapeutic use
US12350336B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2022 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | Apr 9, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6909
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound including a general formula of D-L-A particularly with the structure of Formula (A). A nanoparticle of the compound of the present invention. A pharmaceutical composition including the compound of the present invention as an active ingredient and a pharmaceutically acceptable carrier. A method of treating a target tissue including administering to a patient in need thereof a compound of the present invention and administering to the target tissue radiation in an amount and of a wavelength effective to activate the compound. Also use of the compound of the present invention in preparation of a medicament for treating the target tissue by photodynamic therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.